Kempharm shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Kempharm (ZVRA) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Kempharm
Tip: Access up to 7 years of quarterly data
All positions including Kempharm held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kempharm by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $7.2M | 762k | 9.51 |
| 2025-03-31 | $1.5M | 195k | 7.49 |
| 2024-12-31 | $2.1M | 250k | 8.34 |
| 2024-09-30 | $873k | 126k | 6.94 |
| 2024-06-30 | $169k | 35k | 4.90 |
| 2024-03-31 | $116k | 20k | 5.80 |
| 2023-12-31 | $234k | 36k | 6.55 |
| 2023-09-30 | $146k | 30k | 4.82 |
| 2023-06-30 | $187k | 37k | 5.10 |
| 2023-03-31 | $181k | 33k | 5.50 |
| 2022-12-31 | $107k | 23k | 4.59 |
| 2022-06-30 | $344k | 77k | 4.45 |
| 2022-03-31 | $766k | 152k | 5.03 |
| 2021-12-31 | $1.7M | 191k | 8.71 |
| 2021-09-30 | $1.6M | 169k | 9.33 |
| 2021-03-31 | $312k | 34k | 9.20 |